{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T19:59:07Z","timestamp":1783713547107,"version":"3.55.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,4,16]],"date-time":"2015-04-16T00:00:00Z","timestamp":1429142400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Psych"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s40501-015-0042-9","type":"journal-article","created":{"date-parts":[[2015,4,15]],"date-time":"2015-04-15T05:58:59Z","timestamp":1429077539000},"page":"136-150","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Use of Preclinical Drug Vs. Food Choice Procedures to Evaluate Candidate Medications for Cocaine Addiction"],"prefix":"10.1007","volume":"2","author":[{"given":"Matthew L.","family":"Banks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blake A.","family":"Hutsell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn L.","family":"Schwienteck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Stevens","family":"Negus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,16]]},"reference":[{"key":"42_CR1","unstructured":"UNODC. World Drug Report. 2012 (United Nations publication, Sales No. E.12.XI.1)."},{"key":"42_CR2","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1176\/appi.ajp.162.8.1403","volume":"162","author":"PW Kalivas","year":"2005","unstructured":"Kalivas PW, Volkow ND. The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry. 2005;162:1403\u201313.","journal-title":"Am J Psychiatry"},{"key":"42_CR3","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0893-133X(95)00274-H","volume":"14","author":"NK Mello","year":"1996","unstructured":"Mello NK, Negus SS. Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures. Neuropsychopharmacology. 1996;14:375\u2013424.","journal-title":"Neuropsychopharmacology"},{"key":"42_CR4","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00213-008-1079-x","volume":"199","author":"M Haney","year":"2008","unstructured":"Haney M, Spealman R. Controversies in translational research: drug self-administration. Psychopharmacology. 2008;199:403\u201319.","journal-title":"Psychopharmacology"},{"key":"42_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2008.03.001","volume":"96","author":"SD Comer","year":"2008","unstructured":"Comer SD, Ashworth JB, Foltin RW, Johanson CE, Zacny JP, Walsh SL. The role of human drug self-administration procedures in the development of medications. Drug Alcohol Depend. 2008;96:1\u201315.","journal-title":"Drug Alcohol Depend"},{"key":"42_CR6","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0031-6997(25)06705-5","volume":"27","author":"CR Schuster","year":"1975","unstructured":"Schuster CR. Drugs as reinforcers in monkey and man. Pharmacol Rev. 1975;27:511\u201321.","journal-title":"Pharmacol Rev"},{"key":"42_CR7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/B978-0-12-420118-7.00004-4","volume":"69","author":"LL Howell","year":"2014","unstructured":"Howell LL, Negus SS. Monoamine transporter inhibitors and substrates as treatments for stimulant abuse. Adv Pharmacol. 2014;69:129\u201376.","journal-title":"Adv Pharmacol"},{"key":"42_CR8","first-page":"281768","volume":"2012","author":"ML Banks","year":"2012","unstructured":"Banks ML, Negus SS. Preclinical determinants of drug choice under concurrent schedules of drug self-administration. Adv Pharmacol Sci. 2012;2012:281768.","journal-title":"Adv Pharmacol Sci"},{"key":"42_CR9","volume-title":"Addiction","author":"SS Negus","year":"2013","unstructured":"Negus SS, Banks ML. Medications development for opioid abuse. In: Pierce RC, Kenny PJ, editors. Addiction. New York: Cold Springs Harbor; 2013."},{"key":"42_CR10","doi-asserted-by":"crossref","DOI":"10.2307\/j.ctvjf9xd9","volume-title":"Addiction: a disorder of choice","author":"GH Heyman","year":"2009","unstructured":"Heyman GH. Addiction: a disorder of choice. Cambridge: Harvard University Press; 2009."},{"key":"42_CR11","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1111\/j.1360-0443.2007.01772.x","volume":"102","author":"FJ Vocci","year":"2007","unstructured":"Vocci FJ. Can replacement therapy work in the treatment of cocaine dependence? And what are we replacing anyway? Addiction. 2007;102:1888\u20139.","journal-title":"Addiction"},{"issue":"Supplement 1","key":"42_CR12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.neuropharm.2004.07.019","volume":"47","author":"ND Volkow","year":"2004","unstructured":"Volkow ND, Fowler JS, Wang G-J. The addicted human brain viewed in the light of imaging studies: brain circuits and treatment strategies. Neuropharmacology. 2004;47(Supplement 1):3\u201313.","journal-title":"Neuropharmacology"},{"key":"42_CR13","doi-asserted-by":"crossref","first-page":"7026","DOI":"10.2174\/138161281940131209142843","volume":"19","author":"WW Stoops","year":"2013","unstructured":"Stoops WW, Rush CR. Agonist replacement for stimulant dependence: a review of clinical research. Curr Pharm Des. 2013;19:7026\u201335.","journal-title":"Curr Pharm Des"},{"key":"42_CR14","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3","volume":"39","author":"RB Rothman","year":"2001","unstructured":"Rothman RB, Baumann MH, Dersch CM, Romero DV, Rice KC, Carroll FI, et al. Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse. 2001;39:32\u201341.","journal-title":"Synapse"},{"key":"42_CR15","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.addbeh.2004.06.018","volume":"29","author":"J Grabowski","year":"2004","unstructured":"Grabowski J, Shearer J, Merrill J, Negus SS. Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence. Addict Behav. 2004;29:1439\u201364.","journal-title":"Addict Behav"},{"key":"42_CR16","author":"SS Negus","year":"2014","unstructured":"Negus SS, Henningfield J. Agonist medications for the treatment of cocaine use disorder. Neuropsychopharmacology. 2014. doi: 10.1038\/npp.2014.322 .","journal-title":"Neuropsychopharmacology"},{"key":"42_CR17","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00004714-200110000-00010","volume":"21","author":"J Grabowski","year":"2001","unstructured":"Grabowski J, Rhoades H, Schmitz J, Stotts A, Daruzska LA, Creson D, et al. Dextroamphetamine for cocaine-dependence treatment: a double-blind randomized clinical trial. J Clin Psychopharmacol. 2001;21:522\u20136.","journal-title":"J Clin Psychopharmacol"},{"key":"42_CR18","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/sj.npp.1300392","volume":"29","author":"J Grabowski","year":"2004","unstructured":"Grabowski J, Rhoades H, Stotts A, Cowan K, Kopecky C, Dougherty A, et al. Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials. Neuropsychopharmacology. 2004;29:969\u201381.","journal-title":"Neuropsychopharmacology"},{"key":"42_CR19","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.biopsych.2012.05.032","volume":"72","author":"JJ Mariani","year":"2012","unstructured":"Mariani JJ, Pavlicova M, Bisaga A, Nunes EV, Brooks DJ, Levin FR. Extended-release mixed amphetamine salts and topiramate for cocaine dependence: a randomized controlled trial. Biol Psychiatry. 2012;72:950\u20136.","journal-title":"Biol Psychiatry"},{"key":"42_CR20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fpsyt.2012.00077","volume":"3","author":"JM Schmitz","year":"2012","unstructured":"Schmitz JM, Rathnayaka N, Green C, Moeller FG, Dougherty AE, Grabowski J. Combination of modafinil and d-amphetamine for the treatment of cocaine dependence: a preliminary investigation. Front Psychiatry. 2012;3:77.","journal-title":"Front Psychiatry"},{"key":"42_CR21","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.drugalcdep.2013.05.005","volume":"131","author":"ML Banks","year":"2013","unstructured":"Banks ML, Blough BE, Negus SS. Effects of 14-day treatment with the schedule III anorectic phendimetrazine on choice between cocaine and food in rhesus monkeys. Drug Alcohol Depend. 2013;131:204\u201313. First demonstration of a prodrug (phendimetrazine) treatment efficacy on cocaine vs. food choice in monkeys.","journal-title":"Drug Alcohol Depend"},{"key":"42_CR22","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/sj.npp.1300096","volume":"28","author":"SS Negus","year":"2003","unstructured":"Negus SS. Rapid assessment of choice between cocaine and food in rhesus monkeys: effects of environmental manipulations and treatment with d-amphetamine and flupenthixol. Neuropsychopharmacology. 2003;28:919\u201331.","journal-title":"Neuropsychopharmacology"},{"key":"42_CR23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/jeab.15","volume":"99","author":"M Thomsen","year":"2013","unstructured":"Thomsen M, Barrett AC, Negus SS, Caine SB. Cocaine versus food choice procedure in rats: environmental manipulations and effects of amphetamine. J Exp Anal Behav. 2013;99:211\u201333. First cocaine vs. food choice study in rodents to demonstrate amphetamine treatment efficacy.","journal-title":"J Exp Anal Behav"},{"key":"42_CR24","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1038\/npp.2010.175","volume":"35","author":"MK Greenwald","year":"2010","unstructured":"Greenwald MK, Lundahl LH, Steinmiller CL. Sustained release d-amphetamine reduces cocaine but not \u201cspeedball\u201d-seeking in buprenorphine-maintained volunteers: a test of dual-agonist pharmacotherapy for cocaine\/heroin polydrug abusers. Neuropsychopharmacology. 2010;35:2624\u201337.","journal-title":"Neuropsychopharmacology"},{"key":"42_CR25","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/JCP.0b013e3181d21967","volume":"30","author":"CR Rush","year":"2010","unstructured":"Rush CR, Stoops WW, Sevak RJ, Hays LR. Cocaine choice in humans during D-amphetamine maintenance. J Clin Psychopharmacol. 2010;30:152\u20139.","journal-title":"J Clin Psychopharmacol"},{"key":"42_CR26","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugalcdep.2008.10.016","volume":"101","author":"ME Mooney","year":"2009","unstructured":"Mooney ME, Herin DV, Schmitz JM, Moukaddam N, Green CE, Grabowski J. Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebo-controlled trial. Drug Alcohol Depend. 2009;101:34\u201341.","journal-title":"Drug Alcohol Depend"},{"key":"42_CR27","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/FBP.0b013e32834d63ac","volume":"22","author":"ML Banks","year":"2011","unstructured":"Banks ML, Blough BE, Negus SS. Effects of monoamine releasers with varying selectivity for releasing dopamine\/norepinephrine versus serotonin on choice between cocaine and food in rhesus monkeys. Behav Pharmacol. 2011;22:824\u201336.","journal-title":"Behav Pharmacol"},{"key":"42_CR28","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/npp.2012.193","volume":"38","author":"ML Banks","year":"2013","unstructured":"Banks ML, Blough BE, Stevens Negus S. Interaction between behavioral and pharmacological treatment strategies to decrease cocaine choice in rhesus monkeys. Neuropsychopharmacology. 2013;38:395\u2013404.","journal-title":"Neuropsychopharmacology"},{"key":"42_CR29","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1037\/a0036595","volume":"22","author":"ML Banks","year":"2014","unstructured":"Banks ML, Bauer CT, Blough BE, Rothman RB, Partilla JS, Baumann MH, et al. Abuse-related effects of dual dopamine\/serotonin releasers with varying potency to release norepinephrine in male rats and rhesus monkeys. Exp Clin Psychopharmacol. 2014;22:274\u201384.","journal-title":"Exp Clin Psychopharmacol"},{"key":"42_CR30","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.drugalcdep.2012.10.026","volume":"130","author":"ML Banks","year":"2013","unstructured":"Banks ML, Blough BE, Fennell TR, Snyder RW, Negus SS. Role of phenmetrazine as an active metabolite of phendimetrazine: evidence from studies of drug discrimination and pharmacokinetics in rhesus monkeys. Drug Alcohol Depend. 2013;130:158\u201366.","journal-title":"Drug Alcohol Depend"},{"key":"42_CR31","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1038\/npp.2013.180","volume":"38","author":"ML Banks","year":"2013","unstructured":"Banks ML, Blough BE, Fennell TR, Snyder RW, Negus SS. Effects of phendimetrazine treatment on cocaine vs food choice and extended-access cocaine consumption in rhesus monkeys. Neuropsychopharmacology. 2013;38:2698\u2013707.","journal-title":"Neuropsychopharmacology"},{"key":"42_CR32","author":"ML Banks","year":"2015","unstructured":"Banks ML, Hutsell BA, Blough BE, Poklis JL, Negus SS. Preclinical assessment of Lisdexamfetamine as an agonist medication candidate for cocaine addiction: effects in rhesus monkeys trained to discriminate cocaine or to self-administer cocaine in a cocaine versus food choice procedure. Int J Neuropsychopharmacol. 2015. doi: 10.1093\/ijnp\/pyv009 . First demonstration that the amphetamine prodrug lisdexamfetamine produces amphetamine-like treatment efficacy on cocaine vs. food choice in monkeys.","journal-title":"Int J Neuropsychopharmacol"},{"key":"42_CR33","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3109\/00952999509002711","volume":"21","author":"A Margolin","year":"1995","unstructured":"Margolin A, Avants SK, Kosten TR. Mazindol for relapse prevention to cocaine abuse in methadone-maintained patients. Am J Drug Alcohol Abuse. 1995;21:469\u201381.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"42_CR34","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0376-8716(95)01174-4","volume":"39","author":"SM Stine","year":"1995","unstructured":"Stine SM, Krystal JH, Kosten TR, Charney DS. Mazindol treatment for cocaine dependence. Drug Alcohol Depend. 1995;39:245\u201352.","journal-title":"Drug Alcohol Depend"},{"key":"42_CR35","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0376-8716(95)01198-6","volume":"40","author":"A Margolin","year":"1995","unstructured":"Margolin A, Kosten TR, Avants SK, Wilkins J, Ling W, Beckson M, et al. A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients. Drug Alcohol Depend. 1995;40:125\u201331.","journal-title":"Drug Alcohol Depend"},{"key":"42_CR36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1300\/J069v27n01_02","volume":"27","author":"S Shoptaw","year":"2008","unstructured":"Shoptaw S, Heinzerling KG, Rotheram-Fuller E, Kao UH, Wang P-C, Bholat MA, et al. Bupropion hydrochloride versus placebo, in combination with cognitive behavioral therapy, for the treatment of cocaine abuse\/dependence. J Addict Dis. 2008;27:13\u201323.","journal-title":"J Addict Dis"},{"key":"42_CR37","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.drugalcdep.2005.09.003","volume":"82","author":"SL Collins","year":"2006","unstructured":"Collins SL, Levin FR, Foltin RW, Kleber HD, Evans SM. Response to cocaine, alone and in combination with methylphenidate, in cocaine abusers with ADHD. Drug Alcohol Depend. 2006;82:158\u201367.","journal-title":"Drug Alcohol Depend"},{"key":"42_CR38","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00004714-199712000-00008","volume":"17","author":"J Grabowski","year":"1997","unstructured":"Grabowski J, Roache JD, Schmitz JM, Rhoades H, Creson D, Korszun A. Replacement medication for cocaine dependence: methylphenidate. J Clin Psychopharmacol. 1997;17:485\u20138.","journal-title":"J Clin Psychopharmacol"},{"key":"42_CR39","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1037\/1064-1297.10.3.286","volume":"10","author":"H Schubiner","year":"2002","unstructured":"Schubiner H, Downey KK, Arfken CL, Johanson C-E, Schuster CR, Lockhart N, et al. Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence. Exp Clin Psychopharmacol. 2002;10:286\u201394.","journal-title":"Exp Clin Psychopharmacol"},{"key":"42_CR40","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.drugalcdep.2006.07.004","volume":"87","author":"FR Levin","year":"2007","unstructured":"Levin FR, Evans SM, Brooks DJ, Garawi F. Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo. Drug Alcohol Depend. 2007;87:20\u20139.","journal-title":"Drug Alcohol Depend"},{"key":"42_CR41","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/JCP.0b013e31827bfff4","volume":"33","author":"KM Dursteler-MacFarland","year":"2013","unstructured":"Dursteler-MacFarland KM, Farronato NS, Strasser J, Boss J, Kuntze MF, Petitjean SA, et al. A randomized, controlled, pilot trial of methylphenidate and cognitive-behavioral group therapy for cocaine dependence in heroin prescription. J Clin Psychopharmacol. 2013;33:104\u20138.","journal-title":"J Clin Psychopharmacol"},{"key":"42_CR42","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/sj.npp.1301472","volume":"33","author":"CL Hart","year":"2008","unstructured":"Hart CL, Haney M, Vosburg SK, Rubin E, Foltin RW. Smoked cocaine self-administration is decreased by modafinil. Neuropsychopharmacology. 2008;33:761\u20138.","journal-title":"Neuropsychopharmacology"},{"key":"42_CR43","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/sj.npp.1300600","volume":"30","author":"CA Dackis","year":"2005","unstructured":"Dackis CA, Kampman KM, Lynch KG, Pettinati HM, O\u2019Brien CP. A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology. 2005;30:205\u201311.","journal-title":"Neuropsychopharmacology"},{"key":"42_CR44","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.drugalcdep.2014.05.008","volume":"141","author":"CD Verrico","year":"2014","unstructured":"Verrico CD, Haile CN, Mahoney Iii JJ, Thompson-Lake DGY, Newton TF, De La Garza Ii R. Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: a randomized, double blind, placebo-controlled human laboratory study. Drug Alcohol Depend. 2014;141:72\u20138.","journal-title":"Drug Alcohol Depend"},{"key":"42_CR45","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.drugalcdep.2009.04.015","volume":"104","author":"AL Anderson","year":"2009","unstructured":"Anderson AL, Reid MS, Li S-H, Holmes T, Shemanski L, Slee A, et al. Modafinil for the treatment of cocaine dependence. Drug Alcohol Depend. 2009;104:133\u20139.","journal-title":"Drug Alcohol Depend"},{"key":"42_CR46","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jsat.2011.12.014","volume":"43","author":"CA Dackis","year":"2012","unstructured":"Dackis CA, Kampman KM, Lynch KG, Plebani JG, Pettinati HM, Sparkman T, et al. A double-blind, placebo-controlled trial of modafinil for cocaine dependence. J Subst Abuse Treat. 2012;43:303\u201312.","journal-title":"J Subst Abuse Treat"},{"key":"42_CR47","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1517\/13543784.16.8.1285","volume":"16","author":"SD Comer","year":"2007","unstructured":"Comer SD, Sullivan MA, Hulse GK. Sustained-release naltrexone: novel treatment for opioid dependence. Expert Opin Investig Drugs. 2007;16:1285\u201394.","journal-title":"Expert Opin Investig Drugs"},{"key":"42_CR48","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1001\/archpsyc.63.2.210","volume":"63","author":"SD Comer","year":"2006","unstructured":"Comer SD, Sullivan MA, Yu E, et al. Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial. Arch Gen Psychiatry. 2006;63:210\u20138.","journal-title":"Arch Gen Psychiatry"},{"key":"42_CR49","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1124\/jpet.105.095380","volume":"317","author":"SS Negus","year":"2006","unstructured":"Negus SS. Choice between heroin and food in nondependent and heroin-dependent rhesus monkeys: effects of naloxone, buprenorphine, and methadone. J Pharmacol Exp Ther. 2006;317:711\u201323.","journal-title":"J Pharmacol Exp Ther"},{"key":"42_CR50","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00004714-200006000-00003","volume":"20","author":"J Grabowski","year":"2000","unstructured":"Grabowski J, Rhoades H, Silverman P, Schmitz JM, Stotts A, Creson D, et al. Risperidone for the treatment of cocaine dependence: randomized, double-blind trial. J Clin Psychopharmacol. 2000;20:305\u201310.","journal-title":"J Clin Psychopharmacol"},{"key":"42_CR51","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/105504999305929","volume":"8","author":"FR Levin","year":"1999","unstructured":"Levin FR, McDowell D, Evans SM, Brooks D, Spano C, Nunes EV. Pergolide mesylate for cocaine abuse: a controlled preliminary trial. Am J Addict. 1999;8:120\u20137.","journal-title":"Am J Addict"},{"key":"42_CR52","doi-asserted-by":"crossref","first-page":"480","DOI":"10.4088\/JCP.v69n0321","volume":"69","author":"T Loebl","year":"2008","unstructured":"Loebl T, Angarita GA, Pachas GN, Huang KL, Lee SH, Nino J, et al. A randomized, double-blind, placebo-controlled trial of long-acting risperidone in cocaine-dependent men. J Clin Psychiatry. 2008;69:480\u20136.","journal-title":"J Clin Psychiatry"},{"key":"42_CR53","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jsat.2004.03.009","volume":"27","author":"DA Smelson","year":"2004","unstructured":"Smelson DA, Williams J, Ziedonis D, Sussner BD, Losonczy MF, Engelhart C, et al. A double-blind placebo-controlled pilot study of risperidone for decreasing cue-elicited craving in recently withdrawn cocaine dependent patients. J Subst Abuse Treat. 2004;27:45\u20139.","journal-title":"J Subst Abuse Treat"},{"key":"42_CR54","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0376-8716(03)00009-7","volume":"70","author":"KM Kampman","year":"2003","unstructured":"Kampman KM, Pettinati H, Lynch KG, Sparkman T, O\u2019Brien CP. A pilot trial of olanzapine for the treatment of cocaine dependence. Drug Alcohol Depend. 2003;70:265\u201373.","journal-title":"Drug Alcohol Depend"},{"key":"42_CR55","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1360-0443.2005.00990.x","volume":"100","author":"MS Reid","year":"2005","unstructured":"Reid MS, Casadonte P, Baker S, Sanfilipo M, Braunstein D, Hitzemann R, et al. A placebo-controlled screening trial of olanzapine, valproate, and coenzyme Q10\/L-carnitine for the treatment of cocaine dependence. Addiction. 2005;100:43\u201357.","journal-title":"Addiction"},{"key":"42_CR56","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/10550490802544318","volume":"18","author":"JD Hamilton","year":"2009","unstructured":"Hamilton JD, Nguyen QX, Gerber RM, Rubio NB. Olanzapine in cocaine dependence: a double-blind, placebo-controlled trial. Am J Addict. 2009;18:48\u201352.","journal-title":"Am J Addict"},{"key":"42_CR57","doi-asserted-by":"crossref","first-page":"e1169","DOI":"10.4088\/JCP.13r08525","volume":"74","author":"T Kishi","year":"2013","unstructured":"Kishi T, Matsuda Y, Iwata N, Correll CU. Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials. J Clin Psychiatry. 2013;74:e1169\u201380. A nice review and meta-analysis of dopamine antagonists and other antipsychotic medication treatment effects on cocaine use in clinical trials.","journal-title":"J Clin Psychiatry"},{"key":"42_CR58","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0376-8716(81)90088-0","volume":"8","author":"WL Woolverton","year":"1981","unstructured":"Woolverton WL, Balster RL. Effects of antipsychotic compounds in rhesus monkeys given a choice between cocaine and food. Drug Alcohol Depend. 1981;8:69\u201378.","journal-title":"Drug Alcohol Depend"},{"key":"42_CR59","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00213-014-3672-5","volume":"232","author":"RE Brutcher","year":"2015","unstructured":"Brutcher RE, Nader MA. Effects of quetiapine treatment on cocaine self-administration and behavioral indices of sleep in adult rhesus monkeys. Psychopharmacology. 2015;232:411\u201320.","journal-title":"Psychopharmacology"},{"key":"42_CR60","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1017\/S1461145712000661","volume":"16","author":"J Bergman","year":"2013","unstructured":"Bergman J, Roof RA, Furman CA, Conroy JL, Mello NK, Sibley DR, et al. Modification of cocaine self-administration by buspirone (Buspar\u00ae): potential involvement of D3 and D4 dopamine receptors. Int J Neuropsychopharmacol. 2013;16:445\u201358.","journal-title":"Int J Neuropsychopharmacol"},{"key":"42_CR61","doi-asserted-by":"crossref","first-page":"757","DOI":"10.4088\/JCP.13m08862","volume":"75","author":"TM Winhusen","year":"2014","unstructured":"Winhusen TM, Kropp F, Lindblad R, Douaihy A, Haynes L, Hodgkins C, et al. Multisite, randomized, double-blind, placebo-controlled pilot clinical trial to evaluate the efficacy of buspirone as a relapse-prevention treatment for cocaine dependence. J Clin Psychiatry. 2014;75:757\u201364.","journal-title":"J Clin Psychiatry"},{"key":"42_CR62","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neuropharm.2014.12.024","volume":"92","author":"WS John","year":"2015","unstructured":"John WS, Newman AH, Nader MA. Differential effects of the dopamine D3 receptor antagonist PG01037 on cocaine and methamphetamine self-administration in rhesus monkeys. Neuropharmacology. 2015;92:34\u201343.","journal-title":"Neuropharmacology"},{"key":"42_CR63","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s002130100725","volume":"155","author":"M Haney","year":"2001","unstructured":"Haney M, Ward A, Foltin R, Fischman M. Effects of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration by humans. Psychopharmacology. 2001;155:330\u20137.","journal-title":"Psychopharmacology"},{"key":"42_CR64","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00213-011-2231-6","volume":"216","author":"M Haney","year":"2011","unstructured":"Haney M, Rubin E, Foltin R. Aripiprazole maintenance increases smoked cocaine self-administration in humans. Psychopharmacology. 2011;216:379\u201387.","journal-title":"Psychopharmacology"},{"key":"42_CR65","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1037\/a0035165","volume":"22","author":"MR Lofwall","year":"2014","unstructured":"Lofwall MR, Nuzzo PA, Campbell C, Walsh SL. Aripiprazole effects on self-administration and pharmacodynamics of intravenous cocaine and cigarette smoking in humans. Exp Clin Psychopharmacol. 2014;22:238\u201347.","journal-title":"Exp Clin Psychopharmacol"},{"key":"42_CR66","first-page":"179","volume":"20","author":"M Meini","year":"2011","unstructured":"Meini M, Moncini M, Cecconi D, Cellesi V, Biasci L, Simoni G, et al. Safety, tolerability, and self-rated effects of aripiprazole and ropinirole treatment for cocaine dependence: a pilot study. Am J Addict. 2011;20:179\u201380.","journal-title":"Am J Addict"},{"key":"42_CR67","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00213-008-1245-1","volume":"201","author":"M Thomsen","year":"2008","unstructured":"Thomsen M, Fink-Jensen A, Woldbye D, W\u00f6rtwein G, Sager T, Holm R, et al. Effects of acute and chronic aripiprazole treatment on choice between cocaine self-administration and food under a concurrent schedule of reinforcement in rats. Psychopharmacology. 2008;201:43\u201353.","journal-title":"Psychopharmacology"},{"key":"42_CR68","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1037\/a0014398","volume":"16","author":"J Bergman","year":"2008","unstructured":"Bergman J. Medications for stimulant abuse: agonist-based strategies and preclinical evaluation of the mixed-action D2 partial agonist aripiprazole (Abilify\u00ae). Exp Clin Psychopharmacol. 2008;16:475\u201383.","journal-title":"Exp Clin Psychopharmacol"},{"key":"42_CR69","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1124\/jpet.112.201012","volume":"344","author":"PW Czoty","year":"2013","unstructured":"Czoty PW, Nader MA. Effects of dopamine D2\/D3 receptor ligands on food-cocaine choice in socially housed male cynomolgus monkeys. J Pharmacol Exp Ther. 2013;344:329\u201338.","journal-title":"J Pharmacol Exp Ther"},{"key":"42_CR70","doi-asserted-by":"crossref","unstructured":"John W, Banala A, Newman A, Nader M. Effects of buspirone and the dopamine D3 receptor compound PG619 on cocaine and methamphetamine self-administration in rhesus monkeys using a food-drug choice paradigm. Psychopharmacology 2014:1\u201311.","DOI":"10.1007\/s00213-014-3760-6"},{"key":"42_CR71","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.tins.2012.05.005","volume":"35","author":"ER Butelman","year":"2012","unstructured":"Butelman ER, Yuferov V, Kreek MJ. \u03ba-Opioid receptor\/dynorphin system: genetic and pharmacotherapeutic implications for addiction. Trends Neurosci. 2012;35:587\u201396.","journal-title":"Trends Neurosci"},{"key":"42_CR72","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0022-3565(24)29312-5","volume":"299","author":"SL Walsh","year":"2001","unstructured":"Walsh SL, Geter-Douglas B, Strain EC, Bigelow GE. Enadoline and butorphanol: evaluation of \u03ba-agonists on cocaine pharmacodynamics and cocaine self-administration in humans. J Pharmacol Exp Ther. 2001;299:147\u201358.","journal-title":"J Pharmacol Exp Ther"},{"key":"42_CR73","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s00213-004-1878-7","volume":"176","author":"SS Negus","year":"2004","unstructured":"Negus SS. Effects of the kappa opioid agonist U50,488 and the kappa opioid antagonist nor-binaltorphimine on choice between cocaine and food in rhesus monkeys. Psychopharmacology. 2004;176:204\u201313.","journal-title":"Psychopharmacology"},{"key":"42_CR74","doi-asserted-by":"crossref","unstructured":"Hutsell BA, Cheng K, Rice KC, Negus SS, Banks ML. Effects of the kappa opioid receptor antagonist nor-binaltorphimine (nor-BNI) on cocaine versus food choice and extended-access cocaine intake in rhesus monkeys. Addict Biol. 2015.","DOI":"10.1111\/adb.12206"},{"key":"42_CR75","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00008877-199402000-00009","volume":"5","author":"RW Foltin","year":"1994","unstructured":"Foltin RW, Fischman MW. Effects of buprenorphine on the self-administration of cocaine by humans. Behav Pharmacol. 1994;5:79\u201389.","journal-title":"Behav Pharmacol"},{"key":"42_CR76","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0022-3565(25)20765-0","volume":"278","author":"RW Foltin","year":"1996","unstructured":"Foltin RW, Fischman MW. Effects of methadone or buprenorphine maintenance on the subjective and reinforcing effects of intravenous cocaine in humans. J Pharmacol Exp Ther. 1996;278:1153\u201364.","journal-title":"J Pharmacol Exp Ther"},{"key":"42_CR77","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.drugalcdep.2004.01.006","volume":"74","author":"SS Negus","year":"2004","unstructured":"Negus SS, Mello NK. Effects of chronic methadone treatment on cocaine- and food-maintained responding under second-order, progressive-ratio and concurrent-choice schedules in rhesus monkeys. Drug Alcohol Depend. 2004;74:297\u2013309.","journal-title":"Drug Alcohol Depend"},{"key":"42_CR78","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.cct.2012.11.002","volume":"34","author":"LJ Mooney","year":"2013","unstructured":"Mooney LJ, Nielsen S, Saxon A, Hillhouse M, Thomas C, Hasson A, et al. Cocaine use reduction with buprenorphine (CURB): rationale, design, and methodology. Contemp Clin Trials. 2013;34:196\u2013204.","journal-title":"Contemp Clin Trials"},{"key":"42_CR79","first-page":"309","volume":"3","author":"WL Woolverton","year":"1979","unstructured":"Woolverton WL, Balster RL. The effects of lithium on choice between cocaine and food in the rhesus monkey. Commun Psychopharmacol. 1979;3:309\u201318.","journal-title":"Commun Psychopharmacol"},{"key":"42_CR80","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/archpsyc.1989.01810020019004","volume":"46","author":"FH Gawin","year":"1989","unstructured":"Gawin FH, Kleber HD, Byck R, et al. Desipramine facilitation of initial cocaine abstinence. Arch Gen Psychiatry. 1989;46:117\u201321.","journal-title":"Arch Gen Psychiatry"},{"key":"42_CR81","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1369-1600.2011.00368.x","volume":"17","author":"E Augier","year":"2012","unstructured":"Augier E, Vouillac C, Ahmed SH. Diazepam promotes choice of abstinence in cocaine self-administering rats. Addict Biol. 2012;17:378\u201391. First demonstration of treatment efficacy on cocaine choice\u00a0with a non-monoaminergic releasing compound in rodents.","journal-title":"Addict Biol"},{"key":"42_CR82","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00213-013-3256-9","volume":"231","author":"M Thomsen","year":"2014","unstructured":"Thomsen M, Fulton B, Caine SB. Acute and chronic effects of the M1\/M4-preferring muscarinic agonist xanomeline on cocaine vs. food choice in rats. Psychopharmacology. 2014;231:469\u201379. Recent study demonstrating treatment efficacy to decrease cocaine choice with another potential non-monoaminergic releasing compound.","journal-title":"Psychopharmacology"},{"key":"42_CR83","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF00443407","volume":"97","author":"ME Carroll","year":"1989","unstructured":"Carroll ME, Lac ST, Nygaard SL. A concurrently available nondrug reinforcer prevents the acquisition or decreases the maintenance of cocaine-reinforced behavior. Psychopharmacology. 1989;97:23\u20139.","journal-title":"Psychopharmacology"},{"key":"42_CR84","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF02244304","volume":"105","author":"M Nader","year":"1991","unstructured":"Nader M, Woolverton W. Effects of increasing the magnitude of an alternative reinforcer on drug choice in a discrete-trials choice procedure. Psychopharmacology. 1991;105:169\u201374.","journal-title":"Psychopharmacology"},{"key":"42_CR85","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00008877-200002000-00010","volume":"11","author":"CL Hart","year":"2000","unstructured":"Hart CL, Haney M, Foltin RW, Fischman MW. Alternative reinforcers differentially modify cocaine self-administration by humans. Behav Pharmacol. 2000;11:87\u201391.","journal-title":"Behav Pharmacol"},{"key":"42_CR86","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.pnpbp.2011.10.003","volume":"36","author":"WW Stoops","year":"2012","unstructured":"Stoops WW, Lile JA, Glaser PE, Hays LR, Rush CR. Alternative reinforcer response cost impacts cocaine choice in humans. Prog Neuropsychopharmacol Biol Psychiatry. 2012;36:189\u201393. First human laboratory study to demonstrate cocaine choice in humans is sensitive to \u2018cost\u2019 manipulations.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"42_CR87","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF02245115","volume":"108","author":"MA Nader","year":"1992","unstructured":"Nader MA, Woolverton WL. Effects of increasing response requirement on choice between cocaine and food in rhesus monkeys. Psychopharmacology. 1992;108:295\u2013300.","journal-title":"Psychopharmacology"},{"key":"42_CR88","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.drugalcdep.2014.04.028","volume":"141","author":"MK Greenwald","year":"2014","unstructured":"Greenwald MK, Steinmiller CL. Cocaine behavioral economics: from the naturalistic environment to the controlled laboratory setting. Drug Alcohol Depend. 2014;141:27\u201333. Empirically demonstrated that cocaine use in a naturalistic environment is sensitive to economic variables.","journal-title":"Drug Alcohol Depend"},{"key":"42_CR89","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1001\/archpsyc.1994.03950070060011","volume":"51","author":"ST Higgins","year":"1994","unstructured":"Higgins ST, Budney AJ, Bickel WK, Foerg FE, Donham R, Badger GJ. Incentives improve outcome in outpatient behavioral treatment of cocaine dependence. Arch Gen Psychiatry. 1994;51:568\u201376.","journal-title":"Arch Gen Psychiatry"},{"key":"42_CR90","unstructured":"SAMHSA. Results from the 2013 National Survey on Drug Use and Health: summary of national findings, S.A.a.M.H.S. Administration, Editor. 2014: Rockville, MD."},{"key":"42_CR91","unstructured":"Federal Bureau of Investigation. Crime in the United States. 2014. http:\/\/www.fbi.gov\/about-us\/cjis\/ucr\/crime-in-the-u.s\/2013\/crime-in-the-u.s.-2013\/tables\/table29\/table_29_estimated_number_of_arrests_united_states_2013.xls ."},{"key":"42_CR92","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s00213-005-2266-7","volume":"181","author":"SS Negus","year":"2005","unstructured":"Negus SS. Effects of punishment on choice between cocaine and food in rhesus monkeys. Psychopharmacology. 2005;181:244\u201352.","journal-title":"Psychopharmacology"},{"key":"42_CR93","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00213-011-2501-3","volume":"220","author":"WL Woolverton","year":"2012","unstructured":"Woolverton WL, Freeman KB, Myerson J, Green L. Suppression of cocaine self-administration in monkeys: effects of delayed punishment. Psychopharmacology (Berl). 2012;220:509\u201317.","journal-title":"Psychopharmacology (Berl)"},{"key":"42_CR94","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1038\/npp.2012.99","volume":"37","author":"KA Kerstetter","year":"2012","unstructured":"Kerstetter KA, Ballis MA, Duffin-Lutgen S, Carr AE, Behrens AM, Kippin TE. Sex differences in selecting between food and cocaine reinforcement are mediated by estrogen. Neuropsychopharmacology. 2012;37:2605\u201314. First preclinical study to demonstrate potential gender differences in cocaine choice.","journal-title":"Neuropsychopharmacology"},{"key":"42_CR95","doi-asserted-by":"crossref","first-page":"e79465","DOI":"10.1371\/journal.pone.0079465","volume":"8","author":"AN Perry","year":"2013","unstructured":"Perry AN, Westenbroek C, Becker JB. The development of a preference for cocaine over food identifies individual rats with addiction-like behaviors. PLoS ONE. 2013;8:e79465.","journal-title":"PLoS ONE"},{"key":"42_CR96","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.yhbeh.2009.08.010","volume":"58","author":"SM Evans","year":"2010","unstructured":"Evans SM, Foltin RW. Does the response to cocaine differ as a function of sex or hormonal status in human and non-human primates? Horm Behav. 2010;58:13\u201321.","journal-title":"Horm Behav"},{"key":"42_CR97","doi-asserted-by":"crossref","unstructured":"Banks ML, Blough BE. Effects of environmental manipulations and bupropion and risperidone treatments on choice between methamphetamine and food in rhesus monkeys. Neuropsychopharmacology 2015. doi: 10.1038\/npp.2015.63 .","DOI":"10.1038\/npp.2015.63"},{"key":"42_CR98","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.pbb.2014.11.018","volume":"129","author":"WW Stoops","year":"2015","unstructured":"Stoops WW, Pike E, Hays LR, Glaser PE, Rush CR. Naltrexone and bupropion, alone or combined, do not alter the reinforcing effects of intranasal methamphetamine. Pharmacol Biochem Behav. 2015;129:45\u201350.","journal-title":"Pharmacol Biochem Behav"},{"key":"42_CR99","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.drugalcdep.2008.03.010","volume":"96","author":"S Shoptaw","year":"2008","unstructured":"Shoptaw S, Heinzerling KG, Rotheram-Fuller E, Steward T, Wang J, Swanson A-N, et al. Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence. Drug Alcohol Depend. 2008;96:222\u201332.","journal-title":"Drug Alcohol Depend"}],"container-title":["Current Treatment Options in Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40501-015-0042-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40501-015-0042-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40501-015-0042-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T15:13:07Z","timestamp":1747926787000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40501-015-0042-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,16]]},"references-count":99,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["42"],"URL":"https:\/\/doi.org\/10.1007\/s40501-015-0042-9","relation":{},"ISSN":["2196-3061"],"issn-type":[{"value":"2196-3061","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,16]]}}}